Product
Acoziborole
2 clinical trials
4 indications
Indication
TrypanosomiasisIndication
AfricanIndication
Trypanosoma brucei gambiense infectionIndication
African TrypanosomiasisClinical trial
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Non-parasitologically Confirmed Subjects: a Multicentre Randomised Double-blind Placebo-controlled StudyStatus: Completed, Estimated PCD: 2023-08-02